This article is more than 5 years old. Information may no longer be current.

Radiation oncologist named American Brachytherapy Society fellow

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Eric M. Horwitz, MD, has been named one of the American Brachytherapy Society’s 12 inaugural ABS fellows.

Horwitz, chair of the department of radiation Oncology at Fox Chase Cancer Center, has been with the institution for nearly 20 years. During that time, he has worked to expand its radiation oncology treatment options and patient volumes.

Eric M. Horwitz

Under Horwitz’s leadership, Fox Chase implemented an MRI treatment simulator into prostate cancer treatment and became the first cancer center in the northeastern United States to offer high–dose rate brachytherapy implants to men with prostate cancer.

Horwitz previously served as the president and board chair of the American Brachytherapy Society. He has held the Gerald E. Hanks chair in radiation oncology at Fox Chase since 2009.

“This is a tribute to Dr. Horwitz’s fine career, and his contributions to the field of brachytherapy and to the American Brachytherapy Society,” Steven Frank, MD, president of the society, said in a press release.